NCT06271785Recruiting
Prognostic Value of High-resolution Electrical Source Imaging on the Success of Pediatric Focal Epilepsy Surgery
ISEPEE : Prognostic Value of High-resolution Electrical Source Imaging on the Success of Pediatric Focal Epilepsy Surgery
Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study investigates the usefulness of high resolution electrical source imaging (HR-ESI) in the setting of presurgical evaluation of drug-resistant focal epilepsy in children. This method is based on an estimation of the intra-cerebral source that produces a signal recorded by scalp electrodes by solving the inverse problem, taking into account attenuation factors resulting from particular conductivity properties of the cerebral, peri-cerebral and cranial tissues. Electrical sources are then fused on structural magnetic resonance imaging (MRI). Scalp EEG recorded using 64 to 256 electrodes refers to as high resolution EEG (HR-EEG), leading to HR-ESI. Studies based on small population of children or on mixt population of children and adults showed that HR-ESI has accuracy values, i.e. percentage of true positives (electrical source localized in the brain area resected and success of surgery) and true negatives (electrical source localized outside the brain area resected and failure of surgery) among the total population, ranging from 50 to 80%. Discrepancies between studies could be explained by the limited number of patients included or by the mixture of pediatric and adult data. Another limitation of previously published studies is that the spatial pattern of dipole source distribution was not taken into account to determine prediction accuracy of ESI. Studies using magnetoencephalography (MEG) to perform magnetic source imaging (MSI) suggest that the spatial pattern of dipole source distribution needs to be considered, a spatially-restricted dipole distribution being associated with better post-surgical outcome when resected. To tackle these issues, the investigators aim to conduct the first large prospective multicentric study in children with focal epilepsy candidates to surgery to assess prediction accuracy of ESI based on the finding of tight clusters of dipoles. This is original as this pattern (tight versus loose cluster of dipoles) has been studied by several researchers using MEG but not using HR-EEG. The investigators make the hypothesis that HR-EEG will allow to identity good candidates for epilepsy surgery and thus to offer this underutilized treatment in more children with better post-surgical outcome. Among the secondary objectives, the investigators will address methodological issues related to the resolution of the inverse problem (methods using distributed sources models versus methods based on equivalent dipole estimation), the potential added value to model high-frequency oscillations (HFO), and the investigators will assess the cost-utility of the HR-ESI procedure.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 14 Feb 2024
- Start date
- 15 May 2024
- Primary completion date
- 15 Nov 2026
- Lead sponsor
- University Hospital, Angers
- Diseases
- Epilepsy
- NCT number
- NCT06271785
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 15 May 2024 to the primary completion date, 15 Nov 2026
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Behavioral deficits making recording of scalp EEG impossible without sedation;
- Informed consent form not signed by the parents;
- Patient not affiliated to a social security system
Who the study is looking for
- Age≥2 and \<17 years;
- Drug-resistant focal epilepsy (failure of at least 2 well-conducted drug trials);
- Phase 1 pre-op evaluation with scalp video-EEG recording, MRI and PET-FDG suggesting that the patient could be a good candidate for epilepsy surgery;
- Recent scalp EEG record (within 12 months) showing the presence of interictal spikes;
- High-quality and recent (within 6 months) structural MRI with 3D-T1 sequences covering the whole brain and the scalp available.
Age in the registry: 2 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Angers University Hospital, Pediatric department Coordinator of this site? Confirm its status | Angers | France | Recruiting |
| Lille University Hospital, Clinical Neurophysiology Department Coordinator of this site? Confirm its status | Lille | France | Not yet recruiting |
| Civil Hospices of Lyon, Functional Neurology Department Coordinator of this site? Confirm its status | Lyon | France | Not yet recruiting |
| Marseille Timone University Hospital, Epileptology and Cerebral Rhythmology Department Coordinator of this site? Confirm its status | Marseille | France | Not yet recruiting |
| Nancy University Hospital, Neurology Department Coordinator of this site? Confirm its status | Nancy | France | Not yet recruiting |
| Paris Neck University Hospital, Pediatric department Coordinator of this site? Confirm its status | Paris | France | Not yet recruiting |
| Rothschild Ophtalmologic Fondation, Pediatric neurosurgery Department Coordinator of this site? Confirm its status | Paris | France | Not yet recruiting |
| Paris Robert-Debré University Hospital, Department of Physiology, Pediatric functional explorations Coordinator of this site? Confirm its status | Paris | France | Not yet recruiting |
| Rennes University Hospital, Pediatric department Coordinator of this site? Confirm its status | Rennes | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.